Urgent purchase of fosinopril sodium tablets in Hebei Province

On June 25, Hebei medicine centralized purchase network released the notice of Hebei medicine centralized purchase leading group office on centralized purchase of fosinopril sodium tablets According to the announcement, China US Shanghai Shiguibao Pharmaceutical Co., Ltd., a pilot enterprise selected by the national organization for centralized drug purchase and use, has committed to supply fosinopril sodium tablets (10mg * 14 tablets) at the selected price of national centralized drug purchase in Hebei Province, but the production capacity of the enterprise is not yet able to meet the procurement demand of Hebei Province In accordance with the spirit of the notice of the general office of the people's Government of Hebei Province on printing and distributing the implementation plan for the follow-up and implementation of the pilot work of centralized drug purchase and use organized by the state in Hebei Province ([2019] - 90), in order to ensure the smooth implementation of the follow-up and implementation of the pilot work of centralized drug purchase and use in Hebei Province, Hebei Province plans to invite qualified original research drug manufacturers, reference drug manufacturers, and approved one Before June 26, the manufacturers of the risk assessment and the manufacturers meeting the drug consumption of our province signed up to participate in the centralized procurement of fosinopril sodium tablets (10mg * 14 tablets), so as to ensure the supply of selected drugs in the centralized procurement Recently, media reported that the general office of the people's Government of Hebei Province issued the notice on printing and distributing the implementation plan for the follow-up and implementation of the pilot work of centralized purchase and use of drugs organized by the state in Hebei Province, announcing that all public medical institutions in Hebei Province have followed up the 4 + 7 election results The notice determined that the scope of belt purchase was centralized purchase and pilot drug selection in 25 countries, including atorvastatin and clopidogrel The procurement method is to select the basic procurement quantity of drugs from the estimation of 60% of the total drug consumption of public medical institutions of the province in 2018, and implement volume procurement, volume price linkage, and volume for price Notice requirements: 1 Ensure the use Ensure that the contract consumption is completed within one year; 2 Guarantee the payment collection In principle, the payment shall not exceed 30 days after the acceptance After the contract is signed, the medical insurance fund shall prepay 50% of the purchase amount to the medical institution as agreed in the contract; 3 Ensure the supply of drugs For the behaviors that the quality and quantity of drugs cannot be guaranteed during the implementation, compensation, punishment, withdrawal, alternative and emergency guarantee measures shall be taken; 4 The completion quantity shall be guaranteed On the basis of ensuring the dosage of selected drugs, the remaining dosage of public medical institutions can still purchase other varieties with appropriate price in the integrated application management platform for medical procurement; 5 Adjust the payment policy For the unselected drugs whose price is higher than 4 + 7, the proportion of personal self payment will increase by 10% For the public medical institutions that do not purchase according to the regulations and use the selected drugs, the management shall be strengthened in the form of interview, notification and punishment According to relevant media reports, before that, Hebei Medical Insurance Bureau has had a discussion with 25 selected enterprises in volume procurement, followed up the national pilot volume procurement in the whole province, and implemented the 4 + 7 price selection If it goes well, it is expected to be formally implemented on July 1 Following up on the supply of 4 + 7, some experts have publicly stated that the limit of 4 + 7 volume procurement on the number of bid winning enterprises is risky An enterprise needs to guarantee the whole regional supply of bid winning products, which has too much uncertainty According to the notice on centralized purchase of fosinopril sodium tablets issued by the leading group office of drug centralized purchase of Hebei Province, as for fosinopril sodium tablets (10mg * 14 tablets) selected in 4 + 7, the production capacity of the selected enterprises is not able to meet the purchase demand of 4 + 7 in the whole Province This reminds us that at present, all provinces are actively following up on 4 + 7 Not only Hebei, but also other provinces that are fully following up on 4 + 7 are likely to encounter this problem: the capacity of 4 + 7 medium-sized enterprises is insufficient Now, the 4 + 7 model has been promoted in all provinces For example, Qinghai Province plans to start in June, when purchasing generic drugs that pass and are deemed to pass the consistency evaluation, for the drugs that are purchased in centralized volume by the National Organization (4 + 7 selected drugs), the direct volume will follow the national selected price, and no centralized bidding will be organized Since June 1, public medical institutions in Fujian Province will start to purchase 25 selected varieties, and patients can purchase drugs according to the selected price from June 3 At the State Council's regular policy briefing recently, Chen Jinfu, deputy director of the state health insurance bureau, said that the implementation effect of the pilot drug centralized purchase and use organized by the state was better than expected in general On April 1, the pilot implementation in 11 cities was launched As of 24:00 on April 14, 27.31% of the total agreed procurement has been completed This means that only 14 days after the start-up, 4 + 7 has completed nearly one third of the total procurement This is also an important reason for non pilot cities to follow up 4 + 7 From the perspective of Hebei's practice, after the province's follow-up of 4 + 7, even if the 4 + 7 selected enterprises can not meet the procurement demand, they can also start alternative plans, so that the original research and other enterprises through the consistency evaluation can guarantee the drug supply This will kill two birds with one stone Not only has the drug price been reduced, but also the market supply problem has been solved.